PEG-Intron

Kraj: Nowa Zelandia

Język: angielski

Źródło: Medsafe (Medicines Safety Authority)

Składnik aktywny:

Peginterferon alfa-2b 150ug

Dostępny od:

Schering-Plough a division of Schering-Plough Animal Health Limited

INN (International Nazwa):

Peginterferon alfa-2b 150 µg

Dawkowanie:

150 mcg

Forma farmaceutyczna:

Powder for injection

Skład:

Active: Peginterferon alfa-2b 150ug Excipient: Dibasic sodium phosphate Monobasic sodium phosphate dihydrate Polysorbate 80 Sucrose Water for injection

Sztuk w opakowaniu:

Ampoule, Diluent, 2 mL

Klasa:

Prescription

Typ recepty:

Prescription

Wyprodukowano przez:

Schering-Plough Company

Podsumowanie produktu:

Package - Contents - Shelf Life: Ampoule, Diluent - 2 mL -   - Combination pack, 1 x (Powder + Diluent) - 150 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 2 x (Powder + Diluent) - 300 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Combination pack, 4 x (Powder + Diluent) - 600 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze) - Vial, glass, 1 x 150?g - 150 ?g - 36 months from date of manufacture stored at 2° to 8°C (Refrigerate, do not freeze) 24 hours reconstituted stored at 2° to 8°C (Refrigerate, do not freeze)

Data autoryzacji:

1999-11-16